Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cannabinoid receptor 2 (macrophage) | Starlite/ChEMBL | References |
Homo sapiens | cannabinoid receptor 1 (brain) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0451 | 0.4806 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0806 | 0.8828 | 1 |
Toxoplasma gondii | ferredoxin NADP+ oxidoreductase FNR | 0.0103 | 0.0862 | 0.1794 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.0103 | 0.0862 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.0348 | 0.3634 | 0.3634 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0103 | 0.0862 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0371 | 0.3897 | 0.3321 |
Toxoplasma gondii | NADH-cytochrome b5 reductase 1, putative | 0.0103 | 0.0862 | 0.1794 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0348 | 0.3634 | 0.3634 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0806 | 0.8828 | 0.8828 |
Trypanosoma cruzi | nitrate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0909 | 1 | 1 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0451 | 0.4806 | 0.4316 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0806 | 0.8828 | 0.8159 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0451 | 0.4806 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0909 | 1 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0909 | 1 | 1 |
Leishmania major | NADH-dependent fumarate reductase-like protein | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | oxidoreductase-protein, putative | 0.0103 | 0.0862 | 0.0862 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0103 | 0.0862 | 0.0862 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0132 | 0.1186 | 0.1186 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.0103 | 0.0862 | 0.5 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0132 | 0.1186 | 0.1186 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | p450 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0348 | 0.3634 | 0.5 |
Mycobacterium tuberculosis | Possible oxygenase | 0.0103 | 0.0862 | 0.5 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Leishmania major | hypothetical protein, conserved | 0.0348 | 0.3634 | 0.3634 |
Schistosoma mansoni | hypothetical protein | 0.0371 | 0.3897 | 0.3321 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0909 | 1 | 1 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0909 | 1 | 1 |
Onchocerca volvulus | 0.0103 | 0.0862 | 0.5 | |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0458 | 0.4884 | 0.4402 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Echinococcus granulosus | methionine synthase reductase | 0.0561 | 0.6056 | 0.5684 |
Leishmania major | p450 reductase, putative | 0.0909 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0909 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0806 | 0.8828 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0561 | 0.6056 | 0.6056 |
Plasmodium vivax | ferredoxin--NADP reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Brugia malayi | FAD binding domain containing protein | 0.0561 | 0.6056 | 0.6056 |
Treponema pallidum | flavodoxin | 0.0348 | 0.3634 | 1 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | nitrate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium falciparum | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0909 | 1 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0909 | 1 | 1 |
Leishmania major | cytochrome P450 reductase, putative | 0.0806 | 0.8828 | 0.8828 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Leishmania major | nitrate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Loa Loa (eye worm) | diaphorase | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0348 | 0.3634 | 0.3634 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0909 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0909 | 1 | 1 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0348 | 0.3634 | 0.3634 |
Trypanosoma brucei | NADH-cytochrome b5 reductase-like protein | 0.0103 | 0.0862 | 0.0862 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0348 | 0.3634 | 0.5 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0103 | 0.0862 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0909 | 1 | 1 |
Brugia malayi | diaphorase | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0348 | 0.3634 | 0.3634 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0909 | 1 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0348 | 0.3634 | 0.3634 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium falciparum | ferredoxin--NADP reductase | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Leishmania major | oxidoreductase-like protein | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0909 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0348 | 0.3634 | 0.5 |
Echinococcus granulosus | geminin | 0.0371 | 0.3897 | 0.3321 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0348 | 0.3634 | 0.3634 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0348 | 0.3634 | 0.3634 |
Echinococcus multilocularis | geminin | 0.0371 | 0.3897 | 0.3321 |
Plasmodium vivax | hypothetical protein, conserved | 0.0348 | 0.3634 | 0.3634 |
Brugia malayi | FAD binding domain containing protein | 0.0909 | 1 | 1 |
Trypanosoma cruzi | oxidoreductase-protein, putative | 0.0103 | 0.0862 | 0.0862 |
Leishmania major | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0909 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0909 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0348 | 0.3634 | 0.5 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0348 | 0.3634 | 0.5 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0909 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0909 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0561 | 0.6056 | 0.5684 |
Plasmodium vivax | oxidoreductase NAD-binding domain containing protein | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0909 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0561 | 0.6056 | 0.5684 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0909 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0909 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0132 | 0.1186 | 0.1186 |
Chlamydia trachomatis | sulfite reductase | 0.0561 | 0.6056 | 1 |
Leishmania major | reductase, putative | 0.0103 | 0.0862 | 0.0862 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.